Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Reduction of Short-term Capital Lease Obligations

PALATIN TECHNOLOGIES, INC. Reduction of Short-term Capital Lease Obligations

PALATIN TECHNOLOGIES, INC. (PTN) reported Reduction of Short-term Capital Lease Obligations of $10.93 thousand for the 6-month period ending 2012-12-31, per its 10-Q filed 2013-02-13.

Discontinued › Notes › Leases

us-gaap:ReductionOfShortTermCapitalLeaseObligations · last filed 2013-02-13

  • PALATIN TECHNOLOGIES, INC. reduction of short-term capital lease obligations for the quarter ending 2012-12-31 was $5.51K, a 47.41% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. reduction of short-term capital lease obligations for the quarter ending 2012-09-30 was $5.41K, a 47.24% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. reduction of short-term capital lease obligations for the quarter ending 2012-06-30 was $5.31K, a 36.80% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. reduction of short-term capital lease obligations for the quarter ending 2012-03-31 was $8.87K, a 78.22% increase year-over-year.
  • PALATIN TECHNOLOGIES, INC. reduction of short-term capital lease obligations for fiscal 2012 was $34.92K, a 52.10% increase from fiscal 2011.
  • PALATIN TECHNOLOGIES, INC. reduction of short-term capital lease obligations for fiscal 2011 was $22.96K, a 73.81% decline from fiscal 2010.
  • PALATIN TECHNOLOGIES, INC. reduction of short-term capital lease obligations for fiscal 2010 was $87.67K.
Period endReduction of Short-term Capital Lease Obligations 3 monthReduction of Short-term Capital Lease Obligations 6 monthReduction of Short-term Capital Lease Obligations 9 monthReduction of Short-term Capital Lease Obligations 12 month
2012-12-31$5.51K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13
$10.93K
10-Q · filed 2013-02-13
$16.23K
derived: sum of 3 quarters · filed 2013-02-13
$25.11K
derived: sum of 4 quarters · filed 2013-02-13
2012-09-30$5.41K
10-Q · filed 2012-11-14
$10.72K
derived: sum of 2 quarters · filed 2012-11-14
$19.59K
derived: sum of 3 quarters · filed 2012-11-14
$30.08K
derived: sum of 4 quarters · filed 2013-02-13
2012-06-30$5.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-10
$14.18K
derived: sum of 2 quarters · filed 2012-09-10
$24.67K
derived: sum of 3 quarters · filed 2013-02-13
$34.92K
10-K · filed 2012-09-10
2012-03-31$8.87K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14
$19.36K
derived: sum of 2 quarters · filed 2013-02-13
$29.61K
10-Q · filed 2012-05-14
$38.01K
derived: sum of 4 quarters · filed 2013-02-13
2011-12-31$10.49K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-13
$20.74K
10-Q · filed 2013-02-13
$29.14K
derived: sum of 3 quarters · filed 2013-02-13
$34.12K
derived: sum of 4 quarters · filed 2013-02-13
2011-09-30$10.26K
10-Q · filed 2012-11-14
$18.66K
derived: sum of 2 quarters · filed 2012-11-14
$23.63K
derived: sum of 3 quarters · filed 2012-11-14
$28.49K
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$8.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-10
$13.38K
derived: sum of 2 quarters · filed 2012-09-10
$18.23K
derived: sum of 3 quarters · filed 2012-09-10
$22.96K
10-K · filed 2012-09-10
2011-03-31$4.98K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14
$9.83K
derived: sum of 2 quarters · filed 2012-05-14
$14.56K
10-Q · filed 2012-05-14
2010-12-31$4.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14
$9.58K
10-Q · filed 2012-02-14
2010-09-30$4.73K
10-Q · filed 2011-11-14
2010-06-30$87.67K
10-K · filed 2012-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B